Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations

GLP-1 RAs can be a beneficial adjunct therapy in T1D, improving glycemic control, reducing insulin needs, and supporting weight management, while potentially preventing long-term cardiovascular and renal complications.

Authors

Eda Cengiz (ORCID: https://orcid.org/0000-0001-7992-9506)
Sujatha Seetharaman (ORCID: https://orcid.org/0000-0002-4329-3996)

Institutions

University of California, San Francisco (US)

Publication Details

Journal: Journal of Diabetes Science and Technology
Published: 2024-12-21
DOI: https://doi.org/10.1177/19322968241305641
Citations: 6
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 2.15

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations

Eda Cengiz, Sujatha Seetharaman

Dec 21, 2024

6 citations

Journal of Diabetes Science and Technology

Diabetes Treatment and Management

2.15

article

Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations

Eda Cengiz, Sujatha Seetharaman

December 21, 2024article en

6 citations

Abstract

Journal of Diabetes Science and TechnologyVol. 19(2)

University of California, San Francisco (US)

Good health and well-being

Openalex Percentile: Top 10%

Diabetes Treatment and Management

2.15

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Expectations and Outcomes From Glucagon-Like Peptide-1 Receptor Agonists As Adjunct Treatment for Type 1 Diabetes – Case Presentations — Eda Cengiz, Sujatha Seetharaman · Journal of Diabetes Science and Technology (2024) | TGRS Research Map | TGRS